Patents by Inventor Dimitrios P. Kontoyiannis

Dimitrios P. Kontoyiannis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10835614
    Abstract: The disclosure relates to a class of diol-based, unsaturated aliphatic polyesters that biodegrade into monomers capable of mitigating infection. These poly(diol fumarates) (PDFs) and poly(diol fumarate-co-succinates) (PDFSs), can be crosslinked to form networks of scaffolds with antimicrobial degradation products. Both the diol carbon length and the degree of available double bonds are tunable, resulting in a highly controllable class of antimicrobial polymers useful for cell scaffolds and drug delivery systems and devices.
    Type: Grant
    Filed: September 28, 2018
    Date of Patent: November 17, 2020
    Assignees: William Marsh Rice University, Board of Regents, The University of Texas System
    Inventors: Alexander Mitchell Tatara, Emma Watson, Antonios G. Mikos, Dimitrios P. Kontoyiannis
  • Publication number: 20190091343
    Abstract: The disclosure relates to a class of diol-based, unsaturated aliphatic polyesters that biodegrade into monomers capable of mitigating infection. These poly(diol fumarates) (PDFs) and poly(diol fumarate-co-succinates) (PDFSs), can be crosslinked to form networks of scaffolds with antimicrobial degradation products. Both the diol carbon length and the degree of available double bonds are tunable, resulting in a highly controllable class of antimicrobial polymers useful for cell scaffolds and drug delivery systems and devices.
    Type: Application
    Filed: September 28, 2018
    Publication date: March 28, 2019
    Inventors: Alexander Mitchell Tatara, Emma Watson, Antonios G. Mikos, Dimitrios P. Kontoyiannis
  • Publication number: 20100034739
    Abstract: The disclosure relates to an imaging composition including a fungus-specific peptide and an imaging material. Another imaging composition includes a fungus-specific peptide and a chelator able to chelate a radionuclide. The disclosure also provides to a method of detecting a fungal infection. The method includes administering an imaging agent to a patient. The imaging agent comprises a fungus-specific peptide and an imaging material. Then one may detect the imaging agent in the patient. Detecting retained imaging agent in a tissue or organ indicates fungal infection of the tissue or organ.
    Type: Application
    Filed: May 11, 2007
    Publication date: February 11, 2010
    Applicant: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Chun Li, Dimitrios P. Kontoyiannis